Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
Drug-resistant tuberculosis (TB) is one of the most lethal diseases, and it is imperative to exploit an advanced drug formulation for its effective treatment. This work aims to develop a mannose receptor-targeted bioadhesive chitosan nanoparticles for effective drug-resistant tuberculosis treatment....
Main Authors: | Datta Maroti Pawde, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, Roshan Sonkar, Narendra, Suruchi Poddar, Ankita Sanjay Burande, Abhishek Jha, Kiran Yellappa Vajanthri, Sanjeev Kumar Mahto, V.N. Azger Dustakeer, Madaswamy S. Muthu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016420302437 |
Similar Items
-
Spontaneous mutational patterns and novel mutations for bedaquiline and clofazimine resistance in Mycobacterium tuberculosis
by: Jin Shi, et al.
Published: (2023-10-01) -
Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review
by: Rhea Veda Nugraha, et al.
Published: (2021-05-01) -
Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients
by: Yuanyuan Shang, et al.
Published: (2023-06-01) -
Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
by: Lei Zhang, et al.
Published: (2023-10-01) -
Role of Clofazimine in Treatment of Mycobacterium avium Complex
by: Mohammad Javad Nasiri, et al.
Published: (2021-04-01)